Synopsys chair adds 28 shares via stock plan

Synopsys Inc executive chair Aart de Geus reported an acquisition of 28 shares of Synopsys common stock under the Synopsys, Inc. Employee Stock Purchase Plan.

Rhea-AI Filing Summary

Synopsys Inc executive chair Aart de Geus reported an acquisition of 28 shares of Synopsys common stock under the Synopsys, Inc. Employee Stock Purchase Plan. The transaction used code "J" for other acquisition or disposition at a price of $351.90 per share, bringing his directly held shares to 118,995.

He also reported indirect ownership of 308,791 shares held by a family trust and 14,500 shares held by a partnership, reflecting additional interests associated with him beyond his direct holdings.

Insider Trade Summary

Other: 28 shares

Other 3 txns

Insider DE GEUS AART

Role EXECUTIVE CHAIR

Type	Security	Shares	Price	Value
Other	Common Stock	28	$351.90	$10K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 118,995 shares (Direct); Common Stock — 308,791 shares (Indirect, by Family Trust); Common Stock — 14,500 shares (Indirect, by Partnership)

Footnotes (1)

1. F1. Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Synopsys (SNPS) report for Aart de Geus?

Synopsys reported that executive chair Aart de Geus acquired 28 shares of common stock under the company’s Employee Stock Purchase Plan. This "J"-code transaction is classified as an other acquisition or disposition rather than an open-market buy or sell.

At what price did Aart de Geus acquire Synopsys (SNPS) shares?

Aart de Geus acquired 28 Synopsys common shares at $351.90 per share through the Employee Stock Purchase Plan. This plan-based price applies only to this small acquisition reported in the Form 4 filing.

How many Synopsys (SNPS) shares does Aart de Geus hold directly after this filing?

After this transaction, Aart de Geus directly holds 118,995 shares of Synopsys common stock. This figure reflects only his direct ownership and excludes shares held indirectly through a family trust and a partnership.

What indirect Synopsys (SNPS) holdings are associated with Aart de Geus?

The filing shows indirect ownership of 308,791 shares held by a family trust and 14,500 shares held by a partnership. These positions are reported as indirect interests separate from his directly owned Synopsys shares.

What does transaction code "J" mean in the Synopsys (SNPS) Form 4?

In this Form 4, transaction code "J" is described as an "Other acquisition or disposition". Here, it refers specifically to the acquisition of stock under the Synopsys, Inc. Employee Stock Purchase Plan, not a typical market buy or sell.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 07:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DE GEUS AART

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EXECUTIVE CHAIR

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		J(1)	V	28	A	$351.9	118,995	D
Common Stock								308,791	I	by Family Trust
Common Stock								14,500	I	by Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquisition of stock under Synopsys, Inc Employee Stock Purchase Plan

	By: POA pursuant Mary Lai For: Aart de Geus	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.